Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GAMINYSE:GMRENYSE:PRPBNASDAQ:VINP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGAMIGAMCO Investors$24.30+0.6%$23.71$19.29▼$28.00$541.25M0.766,727 shs252 shsGMREGlobal Medical REIT$7.11-2.2%$6.72$6.06▼$10.46$486.15M1.16505,259 shs773,050 shsPRPBCC Neuberger Principal Holdings II$1.81+4.6%$1.80$7.86▼$10.12$149.87M0.03487,352 shs469,631 shsVINPVinci Partners Investments$9.62-1.5%$9.71$8.66▼$11.62$625.73M0.172,579 shs40,644 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGAMIGAMCO Investors+0.62%+0.62%-2.80%+21.26%-0.82%GMREGlobal Medical REIT-2.27%+2.30%+11.65%-0.35%-21.00%PRPBCC Neuberger Principal Holdings II0.00%+9.04%+9.04%+23.97%-43.96%VINPVinci Partners Investments-1.48%-0.52%+1.05%+8.82%-11.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGAMIGAMCO Investors2.3459 of 5 stars0.04.01.70.02.41.71.3GMREGlobal Medical REIT4.7058 of 5 stars3.33.02.53.62.72.51.3PRPBCC Neuberger Principal Holdings IIN/AN/AN/AN/AN/AN/AN/AN/AVINPVinci Partners Investments3.6537 of 5 stars3.53.01.70.00.61.72.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGAMIGAMCO Investors 0.00N/AN/AN/AGMREGlobal Medical REIT 2.50Moderate Buy$10.4446.80% UpsidePRPBCC Neuberger Principal Holdings II 0.00N/AN/AN/AVINPVinci Partners Investments 3.00Buy$13.2537.73% UpsideCurrent Analyst Ratings BreakdownLatest PRPB, GAMI, VINP, and GMRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025GMREGlobal Medical REITRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $9.004/29/2025VINPVinci Partners InvestmentsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $13.50(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGAMIGAMCO Investors$231.40M2.35$2.29 per share10.59$7.22 per share3.37GMREGlobal Medical REIT$138.78M3.43$0.95 per share7.48$7.20 per share0.99PRPBCC Neuberger Principal Holdings IIN/AN/AN/AN/A($1.42) per shareN/AVINPVinci Partners Investments$111.41M5.53$0.76 per share12.65$5.62 per share1.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGAMIGAMCO Investors$64.46M$2.819.20∞N/A27.86%36.01%23.05%N/AGMREGlobal Medical REIT$6.63M$0.03237.088.461.245.87%1.68%0.65%8/5/2025 (Estimated)PRPBCC Neuberger Principal Holdings II-$2.70MN/A0.00∞N/AN/AN/A-1.58%N/AVINPVinci Partners Investments$21.92M$0.3924.6713.36N/A17.85%12.47%6.77%8/6/2025 (Estimated)Latest PRPB, GAMI, VINP, and GMRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025GMREGlobal Medical REIT$0.23N/AN/AN/A$35.57 millionN/A5/7/2025Q1 2025GMREGlobal Medical REIT$0.22$0.22N/A$0.22$35.49 million$34.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGAMIGAMCO Investors$0.321.32%N/A11.39%1 YearsGMREGlobal Medical REIT$0.608.44%N/A2,000.00%N/APRPBCC Neuberger Principal Holdings IIN/AN/AN/AN/AN/AVINPVinci Partners Investments$0.606.24%N/A153.85%N/ALatest PRPB, GAMI, VINP, and GMRE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/28/2025GMREGlobal Medical REITquarterly$0.159.47%6/20/20257/9/20255/12/2025VINPVinci Partners Investmentsquarterly$0.156.5%5/27/20255/27/20256/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGAMIGAMCO InvestorsN/A2.832.28GMREGlobal Medical REIT1.440.260.26PRPBCC Neuberger Principal Holdings IIN/A0.680.68VINPVinci Partners Investments0.478.318.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGAMIGAMCO Investors3.25%GMREGlobal Medical REIT57.52%PRPBCC Neuberger Principal Holdings IIN/AVINPVinci Partners Investments34.07%Insider OwnershipCompanyInsider OwnershipGAMIGAMCO Investors81.23%GMREGlobal Medical REIT8.50%PRPBCC Neuberger Principal Holdings II0.11%VINPVinci Partners Investments49.31%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGAMIGAMCO Investors17022.41 million4.55 millionNot OptionableGMREGlobal Medical REIT3066.87 million61.19 millionOptionablePRPBCC Neuberger Principal Holdings II482.80 million82.71 millionNot OptionableVINPVinci Partners Investments24064.05 million32.47 millionOptionablePRPB, GAMI, VINP, and GMRE HeadlinesRecent News About These CompaniesVinci Partners Investments (NASDAQ:VINP) Stock Price Down 1.5% - Should You Sell?3 hours ago | marketbeat.comVINP Vinci Partners Investments Ltd. - Seeking AlphaJune 25, 2025 | seekingalpha.comMillennium Management LLC Sells 41,347 Shares of Vinci Partners Investments Ltd. (NASDAQ:VINP)June 14, 2025 | marketbeat.comAnalysts Are Betting On Vinci Partners Investments Ltd. (NASDAQ:VINP) With A Big Upgrade This WeekMay 18, 2025 | finance.yahoo.comVinci Partners Investments Ltd. (NASDAQ:VINP) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This YearMay 16, 2025 | finance.yahoo.comVinci Partners’ Earnings Call Highlights Strong Growth and ChallengesMay 15, 2025 | tipranks.comVinci Partners Reports Strong Q1 2025 Fundraising SuccessMay 15, 2025 | tipranks.comVinci Compass Reports Strong Q1 2025 EarningsMay 12, 2025 | tipranks.comVinci Partners Investments Ltd. (VINP) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comVinci Partners Investments (VINP) Q1 Earnings Meet EstimatesMay 12, 2025 | zacks.comVINCI COMPASS REPORTS FIRST QUARTER 2025 EARNINGS RESULTSMay 12, 2025 | prnewswire.comWhat To Expect From Vinci Partners Investments Ltd (VINP) Q1 2025 EarningsMay 9, 2025 | finance.yahoo.com4 Undervalued Capital Markets Stocks for Thursday, April 24April 24, 2025 | aaii.comAVINCI COMPASS TO ANNOUNCE FIRST QUARTER 2025 RESULTS AND HOST CONFERENCE CALL AFTER MARKET CLOSE ON MONDAY, MAY 12, 2025April 14, 2025 | prnewswire.comStrength Seen in Vinci Partners (VINP): Can Its 5.2% Jump Turn into More Strength?March 18, 2025 | zacks.comVinci Partners’ Earnings Call Highlights Strong Growth and OptimismFebruary 27, 2025 | tipranks.comVinci Compass Reports Robust Growth in 2024 EarningsFebruary 27, 2025 | tipranks.comVinci Compass Reports Strong Growth Amid Strategic AcquisitionsFebruary 26, 2025 | tipranks.comVinci Partners Investments Ltd. (VINP) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comVinci Partners Investments Ltd. 2024 Q4 - Results - Earnings Call PresentationFebruary 26, 2025 | seekingalpha.comVINCI COMPASS REPORTS FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RESULTSFebruary 26, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePRPB, GAMI, VINP, and GMRE Company DescriptionsGAMCO Investors NYSE:GAMI$24.30 +0.15 (+0.62%) As of 07/7/2025 11:12 AM EasternGAMCO Investors, Inc. is a publicly owned holding investment manager. The firm also provides wealth management, investment advisory, institutional research, brokerage, dealer, underwriting, and distribution services to its clients. It provides its services to individuals including high net worth individuals, corporate pension and profit-sharing plans, foundations, endowments, jointly trust plans, municipalities, and investment companies. The firm, through its subsidiaries, manages separate client-focused equity, fixed income, and balanced portfolios. It also launches equity, fixed income, and balanced mutual funds and manages equity mutual funds for its clients. Through its subsidiaries the firm invests in the public equity and fixed income markets across the globe. It invests in value stocks of companies. The firm employs fundamental analysis with a focus on bottom-up stock picking approach to create its portfolios. It conducts in-house research to make its investments. The firm was founded in 1976 and is based in Rye, New York with additional offices in Greenwich, Connecticut; Bannockburn, Illinois; and Tokyo, Japan. GAMCO Investors, Inc. operates as a subsidiary of Ggcp Holdings Llc.Global Medical REIT NYSE:GMRE$7.11 -0.16 (-2.20%) Closing price 07/7/2025 03:59 PM EasternExtended Trading$7.10 -0.02 (-0.21%) As of 07/7/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.CC Neuberger Principal Holdings II NYSE:PRPB$1.81 +0.08 (+4.62%) As of 07/3/2025CC Neuberger Principal Holdings II does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. CC Neuberger Principal Holdings II was incorporated in 2020 and is based in New York, New York.Vinci Partners Investments NASDAQ:VINP$9.62 -0.15 (-1.54%) As of 07/7/2025 04:00 PM EasternVinci Partners Investments Ltd. operates as an asset management firm in Brazil. The company focuses on private markets, liquid strategies, investment products and solutions, and retirement services. It offers private equity, infrastructure, real estate, credit, special situations, equities, hedge funds, and investment products and solutions comprising portfolio and management services. In addition, the company financial and strategic advisory services, focusing on IPO advisory and mergers and acquisition transactions to entrepreneurs, corporate senior management teams, and boards of directors. Vinci Partners Investments Ltd. was founded in 2009 and is based in Rio de Janeiro, Brazil. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
